Gilead Sciences signed joint procurement agreement with the European Commission for Vekluryﾮ (Remdesivir)
On Jul. 19, 2022, Gilead Sciences and the European Commission announced a new joint procurement agreement (JPA) that…
Yale-developed vaccine offers superior protection against Omicron variants
On Jul. 19, 2022, Yale scientists announced they had developed a novel Omicron-specific mRNA vaccine that offers superior…
Vaccine-induced immune response to Omicron wanes substantially over time
On Jul. 19, 2022, the NIH announced that although COVID-19 booster vaccinations in adults elicit high levels of…
Ghana declared first-ever outbreak of Marburg virus disease
On Jul. 17, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades
On Jul. 15, 2022, The largest sustained decline in childhood vaccinations in approximately 30 years has been recorded…
Aegis Sciences begin Monkeypox testing, increasing nationwide testing capacity
On Jul 14. 2022, Aegis Sciences announced it is was authorized to begin testing for monkeypox using the…
Quest Diagnostics launched Monkeypox virus testing
On Jul. 13, 2022, Quest Diagnostics announced that it had announced the nationwide availability* of the company’s lab-developed…
Quest Diagnostics launched Monkeypox virus testing
On Jul 13. 2022, Quest Diagnostics announced the nationwide availability of the company’s lab-developed molecular diagnostic test to…
Pfizer and BioNTech submitted a variation to EMA for vaccination of children ages 6 months to less than 5 Years with COMIRNATY
On Jul. 8, 2022, Pfizer and BioNTech announced that the companies had submitted a variation to the European…
Labcorp first national laboratory to offer Monkeypox test
On Jul. 6, 2022, LabCorp announced that it had begun testing for monkeypox using the U.S. Centers for…
COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses
On Jul. 5, 2022, Tgen and Northern Arizona University announced that a research team found that the vaccine…
NIH study revealed how immune response triggered by COVID-19 may damage the brain
On Jul. 5, 2022, the National Institutes of Health released a study that described the immune response triggered…
Pfizer and BioNTech announced agreement with U.S. Government to provide additional doses of COVID-19 Vaccine
On Jun. 30, 2022, Pfizer and BioNTech announced a vaccine supply agreement with the U.S. government to support…
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Disease | FDA | Life Science History | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 Wheel of Fortune
Play the COVID-19 Wheel of Fortune and see how lucky you are! You have two wheels to choose…
Pfizer and BioNTech announced Omicron-adapted COVID-19 vaccine candidates demonstrated high immune response
On Jun. 24 2022, Pfizer and BioNTech announced positive data evaluating the safety, tolerability, and immunogenicity of two…
Emergent BioSolutions announced FDA acceptance of Biologics License Application for AV7909 Anthrax vaccine candidate
On Jun. 24, 2022, Emergent BioSolutions announced that the U.S. Food and Drug Administration accepted for review the…
BioNTech started construction of first mRNA vaccine manufacturing facility in Africa
On Jun. 23, 2022, BioNTech announced it had reached a milestone in the establishment of scalable mRNA vaccine…
Pfizer-BioNTech COVID-19 vaccine received FDA Emergency Use Authorization for children 6 months through 4 years of age
On Jun. 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration had granted emergency use…
Origins of the Black Death identified
On Jun, 15, 2022, a multidisciplinary team of scientists, announced they had obtained and studied ancient Y. pestis…
Roche received FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and measure viral load levels of COVID-19
On Jun. 15, 2022, Roche announced that the US Food and Drug Administration had issued Emergency Use Authorization…
Hospitalizations and mortality rates higher for cancer patients with breakthrough SARS-CoV-2 infections, studies showed
On Jun. 10, 2022, researchers from Case Western Reserve School of Medicine, Case Comprehensive Cancer Center, and The…
Backyard poultry contact linked to more than 200 Salmonella illnesses in 2022
On Jun. 10, 2022, CDC and public health officials in several states announced they were investigating multistate outbreaks…
Common drug-resistant superbug developed fast resistance to ﾑlast resortﾒ antibiotic
On Jun. 7, 2022, the University of Oxford reported new research has found that Pseudomonas bacterium develops resistance…
Genetically modified corn does not damage non-target organisms
On Jun. 6, 2022, the U.S. Department of Agriculture (USDA) reported that the largest, highest quality analysis of…
Serological evidence for SARS-CoV-2 in lactating cows published
On Jun. 4, 2022, researchers reported that in areas with large cattle populations and a high prevalence of…
Immune modulator drugs improved survival for people hospitalized with COVID-19
On Jun. 2, 2022, the U.S. National Institutes of Health announced that a large randomized, placebo-controlled clinical trial…
Food allergy associated with lower risk of SARS-CoV-2 infection
On Jun. 1, 2022, the U.S. National Institutes of Health announced that an NIH funded study had found…
Ultima Genomics delivered the $100 genome
On May 31, 2022, Ultima Genomics emerged from stealth business mode with a new high-throughput, low-cost sequencing platform…
Relief reports that its U.S. collaboration partner announced DSMB recommended termination of ACTIV-3b study in critical COVID-19
On May 26, 2022, RELIEF THERAPEUTICS announced that the parent company, NRx Pharmaceuticals, of its collaboration partner with…
Pfizer-BioNTech COVID-19 vaccine demonstrated strong immune response in children 6 months to under 5 years of age following third dose
On May 25, 2022, Pfizer and BioNTech announced topline safety, immunogenicity and vaccine efficacy data from a Phase…